{"@type":"dcat:Dataset","accessLevel":"public","bureauCode":["009:38"],"contactPoint":{"fn":"admin","hasEmail":"mailto:HealthData@hhs.gov"},"description":"<p>Accounting for Unobservable Exposure Time Bias When Using Medicare Prescription Drug Data<br />\nUnobservable exposure time is common among Medicare Part D beneficiaries, and they are often in worse health. To retain patients with unobservable exposure time, we recommend stratifying patients on receipt of post-acute facility-based care, calculating and using observable days as a covariate and, when appropriate, using the discharge date from contiguous post-acute facility care for beginning the exposure assessment period.</p>\n","identifier":"da690a2d-644a-4e97-b358-301d286020b3","keyword":["acute-care-hospital","hospital","inpatient","long-term-care-ltc","medicare","national","nursing-home","part-d","pharmacy","prescription-drugs","psychiatric-facility","publications","skilled-nursing-snf"],"language":["en"],"modified":"2015-10-30","publisher":{"@type":"org:Organization","name":"Department of Health &amp; Human Services"},"title":"Accounting for Unobservable Exposure Time Bias Wh...","programCode":["009:000"]}
